File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The Prevalence and Factors of Dyspnea Among Advanced Cancer Survivors

TitleThe Prevalence and Factors of Dyspnea Among Advanced Cancer Survivors
Other TitlesA Systematic Review and Meta-analysis
Authors
Issue Date1-Apr-2025
PublisherLippincott, Williams & Wilkins
Citation
Cancer Nursing, 2025 How to Cite?
Abstract

Background 

Dyspnea is a significant symptom in advanced cancer patients, yet comprehensive evidence on its prevalence and related factors is lacking.

Objective 

This review aims to summarize the prevalence of dyspnea among advanced cancer survivors and identify associated factors.

Methods 

MEDLINE, EMBASE, Cochrane Library, PsycINFO, CINAHL Plus, and Web of Science were searched from inception to May 2024. Observational studies focusing on advanced cancer patients reporting dyspnea were included. Two reviewers performed data extraction and quality assessment independently using the Newcastle-Ottawa Scale. Prevalence estimates were pooled using a random-effects model. Subgroup analyses and metaregression were performed to explore heterogeneity.

Results 

A total of 67 studies involving 78 409 advanced cancer survivors were included, revealing a pooled prevalence of dyspnea of 43% (95% prediction interval, 0.07, 0.84). Significant variations were observed based on cancer types, with lung cancer showing a prevalence of 55%. Factors associated with dyspnea were categorized using the Breathing, Thinking, Functioning clinical model: (1) breathing: physical (eg, fatigue), medical (eg, lung disease), and treatment-related (eg, palliative sedation) factors; (2) thinking: psychological (eg, anxiety) factors; and (3) functioning: performance (eg, Karnofsky Performance Status) and demographic characteristics (eg, age).

Conclusions 

The findings highlight a high prevalence of dyspnea among advanced cancer survivors and identify several associated factors, stressing the need for early detection and comprehensive management strategies.

Implications for Practice 

Health providers can improve the quality of life for patients by effectively managing dyspnea, thereby reducing symptom burden, and alleviating psychological distress, leading to better overall well-being for patients and caregivers.


Persistent Identifierhttp://hdl.handle.net/10722/355809
ISSN
2023 Impact Factor: 2.4
2023 SCImago Journal Rankings: 0.767

 

DC FieldValueLanguage
dc.contributor.authorHou, Tianxue-
dc.contributor.authorHo, Mu-Hsing-
dc.contributor.authorJia, Shumin-
dc.contributor.authorLin, Chia-Chin-
dc.date.accessioned2025-05-16T00:35:13Z-
dc.date.available2025-05-16T00:35:13Z-
dc.date.issued2025-04-01-
dc.identifier.citationCancer Nursing, 2025-
dc.identifier.issn0162-220X-
dc.identifier.urihttp://hdl.handle.net/10722/355809-
dc.description.abstract<h3>Background </h3><p>Dyspnea is a significant symptom in advanced cancer patients, yet comprehensive evidence on its prevalence and related factors is lacking.</p><h3>Objective </h3><p>This review aims to summarize the prevalence of dyspnea among advanced cancer survivors and identify associated factors.</p><h3>Methods </h3><p>MEDLINE, EMBASE, Cochrane Library, PsycINFO, CINAHL Plus, and Web of Science were searched from inception to May 2024. Observational studies focusing on advanced cancer patients reporting dyspnea were included. Two reviewers performed data extraction and quality assessment independently using the Newcastle-Ottawa Scale. Prevalence estimates were pooled using a random-effects model. Subgroup analyses and metaregression were performed to explore heterogeneity.</p><h3>Results </h3><p>A total of 67 studies involving 78 409 advanced cancer survivors were included, revealing a pooled prevalence of dyspnea of 43% (95% prediction interval, 0.07, 0.84). Significant variations were observed based on cancer types, with lung cancer showing a prevalence of 55%. Factors associated with dyspnea were categorized using the Breathing, Thinking, Functioning clinical model: (1) breathing: physical (eg, fatigue), medical (eg, lung disease), and treatment-related (eg, palliative sedation) factors; (2) thinking: psychological (eg, anxiety) factors; and (3) functioning: performance (eg, Karnofsky Performance Status) and demographic characteristics (eg, age).</p><h3>Conclusions </h3><p>The findings highlight a high prevalence of dyspnea among advanced cancer survivors and identify several associated factors, stressing the need for early detection and comprehensive management strategies.</p><h3>Implications for Practice </h3><p>Health providers can improve the quality of life for patients by effectively managing dyspnea, thereby reducing symptom burden, and alleviating psychological distress, leading to better overall well-being for patients and caregivers.</p>-
dc.languageeng-
dc.publisherLippincott, Williams & Wilkins-
dc.relation.ispartofCancer Nursing-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleThe Prevalence and Factors of Dyspnea Among Advanced Cancer Survivors-
dc.title.alternativeA Systematic Review and Meta-analysis-
dc.typeArticle-
dc.identifier.doi10.1097/NCC.0000000000001490-
dc.identifier.eissn1538-9804-
dc.identifier.issnl0162-220X-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats